Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Compugen Ltd. (CGEN)

3.95 0 (0%)

09-21 16:00

Open:

3.95

Pre. Close:

3.95

High:

4

Low:

3.85

Volume:

99,079

Market Cap:

226M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.009 - 4.029

4.029 - 4.045

Low:

3.796 - 3.823

3.823 - 3.844

Close:

3.912 - 3.953

3.953 - 3.986

Technical analysis  (as of: 2018-09-21 4:24:29 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 4.79     One year: 5.59

Support:

Support1: 3.61    Support2: 3.30

Resistance:

Resistance1: 4.10    Resistance2: 4.79

Pivot:

3.89

Moving Averages:

MA(5): 3.87     MA(20): 3.87

MA(100): 3.50     MA(250): 3.40

MACD:

MACD(12,26): 0.11     Signal(12,26,9): 0.13

%K %D:

%K(14,3): 55.56     %D(3): 47.65

RSI:

RSI(14): 60.97

52-Week:

High: 5  Low: 2.25  Change(%):

Average Vol(K):

3-Month: 16094  10-Days 13954

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CGEN has closed below upper band by 23.4%. Bollinger Bands are 68.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CGEN's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-09-20T08:47:16-04:00
Compugen receives milestone payment in cancer immunotherapy collaboration with Bayer

2018-09-20T07:00:00-04:00
Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration With Bayer Following Dosing of First Patient in BAY 1905254 Phase 1 Trial

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

57.20

Shares Float (M)

57.20

% Held by Insiders

% Held by Institutions

18.20

Shares Short (K)

2860

Shares Short Prior Month (K)

Stock Financials

EPS

-0.560

EPS Est. Current Year

-0.730

EPS Est. Next Year

-0.830

EPS Est. Next Quarter

-0.190

Forward EPS

-0.810

Book Value (p.s.)

5.430

PEG Ratio

Profit Margin

Operating Margin

-295.84

Return on Assets (ttm)

-54.2

Return on Equity (ttm)

-65.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.174

Qtrly Earnings Growth

Operating Cash Flow (M)

-23.45

Levered Free Cash Flow (M)

-11.86

Valuation

P/E

-7.05

P/E Growth Ratio

P/BV

0.73

P/S

1189157888.00

P/CF

-9.63

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.